Introduction ▼
Extramedullary hematopoiesis (EMH) is a pathophysiological compensatory response due to insufficient erythrogenesis seen in leukemia and myeloproliferative diseases such as myelofibrosis (MF). It consists of diffuse proliferation of erythroid precursors outside the bone marrow in reticuloendothelial organs such as the spleen, liver and lymph nodes. Nodular EMH, a morphological variant, is rarely found in the spleen. These lesions have previously been reported as hyperechoic on ultrasound (US), but only a few cases presented a histopathological correlation. Contrast-enhanced ultrasound (CEUS) is considered to be a particularly valuable tool for nodular lesions detected on B-mode US because of its ability to differentiate benign from malignant (Görg C. Eur J of Radiology 2007; 64: 189 -201) . However, to date only one case of hyperechoic splenic lesions studied with CEUS with histopathological correlation has been reported (Huynh MQ et al. Ultraschall in Med 2009; 30: 297 -299) .
Case Report ▼
A 37-year-old male in good health with no previous medical history was referred by his family practitioner to our university hospital because of a two-day history of abdominal pain, diarrhea, nausea and nocturnal sweating. A contrast-enhanced computed tomography (CECT) scan with a native study was performed in our department and excluded inflammatory abdominal disease 
Fallbericht ▼
Ein 37-jähriger gesunder Mann ohne klinische Vorgeschichte wurde aufgrund von über 2 Tage fortdauernden Bauchschmerzen, Durchfall, Übelkeit und Nachtschweiß von seinem Hausarzt and acute aortic syndrome. However, an enlarged spleen, measuring 33 × 21 × 11 cm, was detected along with a round, well-delineated splenic mass measuring 6 × 5 × 5 cm in the inferior-medial splenic region and was spontaneously hypodense at 72 HU with weak homogenous enhancement at 84 HU in the portal phase (q Fig. 1a, b) .
Subsequently, abdominal ultrasound (US) was performed to further characterize the splenomegaly and the aforementioned mass. The round, well-delineated intrasplenic mass was confirmed and appeared homogenous and hyperechoic on B-mode (q Fig. 2) . Contrast-enhanced ultrasound was then performed using injected sulfur hexafluoride microbubbles (SonoVue ® , Bracco, Milan, Italy). Initially, during the arterial phase, the mass appeared hypoechoic, followed by a continued homogenous hypoechoic appearance in the venous and late phases (q Fig. 3a-c) .
The complete blood count and biochemical blood analysis showed a left-shift without leukocytosis and LDH at 588 U/l. A peripheral blood smear revealed the presence of dacryocytes and megakaryocytes. Faced with a possible hematological disease, a bone marrow biopsy was performed, demonstrating morphological anomalies and an increase in the number of granulocyte precursors and megakaryocytes along with grade-three reticular fibrosis, thus establishing the diagnosis of primary MF, which was eventually corroborated by positivity for a JAK2 V617F mutation. The intramedullary blast cell count was in the normal range.
Since the imaging features of a splenic lesion were undetermined, a US-guided full core biopsy (Biopince™ 18G, Angiotech, Stenløse, Denmark) was performed. It revealed loose clusters of large atypical megakaryocytes with hyperchromatic and irregular nuclei of various sizes confirmed by factor VIII positivity using immunohistochemistry. Moreover, other hematopoetic precursors of erythocytic and granulocytic lineages were detected without any visible blast cells (q Fig. 4a-e ). Splenic EMH was confirmed in the context of an underlying MF.
Ruxolitinib, a Janus Kinase inhibitor for subtype JAK2, was initiated immediately and the patient was discharged from the hospital after a decrease in abdominal pain. A follow-up at six months showed favorable clinical improvement and a reduction in the overall spleen size from 33 cm to 18 cm.
Discussion ▼
In the radiological work-up of MF, splenic EMH typically appears as a diffuse infiltration (Singer A et al. Abdominal Imaging 2009; 29: 710 -712) . Focal splenic lesions in MF, however, are more challenging to attribute to a specific pathology.
Abdominal B-mode allows the characterization of focal lesions based on echogenicity. Unfortunately, many focal splenic lesions such as cysts, metastases, abscesses, hematomas, hemangioma and infarctions may appear as both hyper-and hypoechoic ( Benter T et al. J Ultrasound Med 2011; 30: 1281 -1293 whereas benign lesions appear iso-or hyperenhancing with slow washout. However, focal splenic lesions with a hyperechoic appearance show varied enhancement levels and thus CEUS has limited applicability for their characterization (Stang A et al. Ultraschall in Med 2011; 32: 582 -592) .
The CEUS enhancement characteristics of the hyperechoic splenic lesion seen in our patient was observed to be different from a report previously published in this journal, which described a nearly isoechoic appearance in the arterial and venous phases (Huynh MQ et al. Ultraschall in Med 2009; 30: 297 -299) . We report no enhancement in the arterial phase extending into the venous and late phases, which constantly remained relatively hypoechoic with respect to the splenic parenchyma. Moreover, the lack of enhancement, related to a reduced vascularization compared to the surrounding splenic parenchyma, corresponds with the results of our initial CECT.
Because of the rarity of nodular hyperechoic lesions in MF coupled with a hesitation to perform biopsy, most lesions remain undiagnosed and thus unreported in the literature. In our patient, a US-guided core biopsy was warranted in part because of the absence of thrombocytopenia and hematological disorders. Therefore, we would like to point out that in both CECT and CEUS the lesion did not show any enhancement during the whole vascular study in contradiction with the previous reported case. 
